Preclinical Models

Abstract PO-074: Identification of C-MET receptor as a therapeutic target in patient-specific tumoroid models of metastatic pancreatic adenocarcinoma allows identification of a new mode of action for its inhibitors

Pub Date : 2021-11-15 DOI: 10.1158/1538-7445.panca21-po-074 Liam Deems, M. Ivanova, C. Murphy, Amit Shahar, D. Deems, D. Shvartsman

Abstract PO-070: Longitudinal precision oncology platform to identify chemotherapy-induced vulnerabilities in pancreatic cancer

Pub Date : 2021-11-15 DOI: 10.1158/1538-7445.panca21-po-070 K. Peschke, Hannah Jakubowski, A. Schäfer, Carlo Maurer, S. Lange, F. Orben, Raquel Bernad, Felix N. Harder, M. Eiber, R. Öllinger, M. Schlitter, W. Weichert, V. Phillip, C. Schlag, R. Schmid, R. Braren, B. Kong, E. Demir, H. Friess, R. Rad, D. Saur, G. Schneider, M. Reichert

Abstract PO-062: EUS-guided biopsy of pancreatic mass lesions for the development of patient-derived organoids in Puerto Rico

Pub Date : 2021-11-15 DOI: 10.1158/1538-7445.panca21-po-062 Andrea S. Flores Pérez, J. Vega, Ana M. Reyes Ramos, C. Micames, M. Torres-Lugo, Maribella Domenech